摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Glu(OtBu)-Ala-OMe | 42538-76-1

中文名称
——
中文别名
——
英文名称
Glu(OtBu)-Ala-OMe
英文别名
γ-tert-butyl-L-glutamyl-L-alanine methyl ester
Glu(OtBu)-Ala-OMe化学式
CAS
42538-76-1
化学式
C13H24N2O5
mdl
——
分子量
288.344
InChiKey
GXJJFZOUNTUQKB-IUCAKERBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    430.8±45.0 °C(Predicted)
  • 密度:
    1.106±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.11
  • 重原子数:
    20.0
  • 可旋转键数:
    6.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    107.72
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Glu(OtBu)-Ala-OMe 氢气一水合肼溶剂黄146三乙胺 作用下, 以 甲醇乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 反应 65.0h, 生成 N-tert-butoxycarbonyl-O-benzyl-L-seryl-L-histidyl-L-leucyl-L-valyl-γ-tert-butyl-L-glutamyl-L-alanine hydrazide
    参考文献:
    名称:
    Kolomeitseva, L. A.; Kocharova, N. A.; Ibragimova, L. D., Journal of general chemistry of the USSR, 1982, vol. 52, # 2, p. 372 - 377
    摘要:
    DOI:
  • 作为产物:
    描述:
    Z-Glu(O-t-Bu)-Ala-OMe 在 palladium on activated charcoal 盐酸氢气 作用下, 以 甲醇 为溶剂, 生成 Glu(OtBu)-Ala-OMe
    参考文献:
    名称:
    Die Synthese von Insulinfragmenten mit intakter interchenarer Disulfidbrücke A20-B19
    摘要:
    AbstractThe synthesis of six insulin fragments is described, in which various sequences of the two chains are linked by the disulfide bridge between A20 and B19. The fragments in question are: A20–21–B19–21, A20–21–B18–21, A20–21–B17–21, A19–21–B19–21, A16–21–B18–21 and A20–21–B12–21.In order to build up the simpler fragments the disulfide bridge was established by oxidation with iodine of two S‐trityl cysteine peptides in which the carboxyl and amino groups were protected by the t‐butyl and t‐butyloxycarbonyl residue. From the mixture obtained the unsymmetrical cystine peptide was separated in all cases from the two symmetrical ones by counter‐current distribution.In the synthesis of the more complex fragments advantageous use was made of smaller unsymmetrical fragments prepared as above but having one amino group protected by the N‐trityl residue. After selective elimination of this group it was possible to lengthen the peptide chain at this position.The free peptides were obtained by removal of the protecting groups with strong acids, in particular concentrated hydrochloric acid. While in this deprotecting step the disulfide bond was stable, conditions are discussed under which disproportionation was observed.None of the six synthetic insulin fragments showed activity in stimulating rat adipose tissue to convert 14C‐labelled glucose to CO2 in vitro.
    DOI:
    10.1002/hlca.19710540143
点击查看最新优质反应信息

文献信息

  • Macrocyclization of Peptide Side Chains by the Ugi Reaction: Achieving Peptide Folding and Exocyclic <i>N</i>-Functionalization in One Shot
    作者:Aldrin V. Vasco、Carlos S. Pérez、Fidel E. Morales、Hilda E. Garay、Dimitar Vasilev、José A. Gavín、Ludger A. Wessjohann、Daniel G. Rivera
    DOI:10.1021/acs.joc.5b00858
    日期:2015.7.2
    The cyclization of peptide side chains has been traditionally used to either induce or stabilize secondary structures (beta-strands, helices, reverse turns) in short peptide sequences. So far, classic peptide coupling, nucleophilic substitution, olefin metathesis, and click reactions have been the methods of choice to fold synthetic peptides by means of macrocyclization. This article describes the utilization of the Ugi reaction for the side chain-to-side chain and side chain-to-termini macrocydization of peptides, thus enabling not only access to stable folded structures but also the incorporation of exocydic functionalities as N-substituents. Analysis of the NMR-derived structures revealed the formation of helical turns, beta-bulges, and a-turns in cyclic peptides cross-linked at i, i + 3 and i, i + 4 positions, proving the folding effect of the multicomponent Ugi macrocyclization. Molecular dynamics simulation provided further insights on the stability and molecular motion of the side chain cross-linked peptides.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸